Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism

被引:287
|
作者
Spires, TL [1 ]
Grote, HE [1 ]
Varshney, NK [1 ]
Cordery, PM [1 ]
van Dellen, A [1 ]
Blakemore, C [1 ]
Hannan, AJ [1 ]
机构
[1] Univ Oxford, Physiol Lab, Oxford OX1 3PT, England
来源
JOURNAL OF NEUROSCIENCE | 2004年 / 24卷 / 09期
基金
英国惠康基金;
关键词
Huntington's disease; environmental enrichment; BDNF; DARPP-32; transgenic mouse model; R6/1; NGF;
D O I
10.1523/JNEUROSCI.1658-03.2004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by a CAG repeat expansion encoding an extended polyglutamine tract in the huntingtin protein. Transgenic mice expressing a human huntingtin transgene containing an expanded CAG repeat (R6/1 model) develop a neurodegenerative disorder closely resembling human HD. Previous work demonstrated that environmental enrichment delays the onset of motor symptoms in this mouse model. We confirmed that at 5 months of age, enrichment ameliorates motor symptoms ( assessed using the rotarod test) and prevents loss of body weight induced by the HD transgene. We further examined molecular consequences of enrichment by determining changes in protein levels in the neostriatum, hippocampus, and anterior cortex using quantitative Western blot analysis. Non-enriched HD mice have severe reductions in BDNF in the hippocampus and striatum at 5 months, which are entirely rescued by enrichment. BDNF levels are unaltered by HD in the anterior cortex, suggesting that enrichment might prevent HD-induced impairment of anterograde transport of this neurotrophin to the striatum. NGF is unaffected by HD. Non-enriched HD mice also exhibit deficits in dopamine and cAMP-regulated phosphoprotein ( 32 kDa) in striatum and anterior cortex. Environmental enrichment rescues the cortical but not the striatal deficit at 5 months. These results suggest that environmental enrichment benefits animals at early stages of the disease by rescuing protein deficits, possibly through rescuing transcription or protein transport problems.
引用
收藏
页码:2270 / 2276
页数:7
相关论文
共 50 条
  • [21] Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice
    Placido, Evelini
    Gomes Welter, Priscilla
    Wink, Ana
    Karasiak, Gabriela Duarte
    Outeiro, Tiago Fleming
    Dafre, Alcir Luiz
    Gil-Mohapel, Joana
    Brocardo, Patricia S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [22] Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington's disease
    Santos, Rebeca P. M.
    Ribeiro, Roberta
    Ferreira-Vieira, Talita H.
    Aires, Rosaria D.
    de Souza, Jessica M.
    Oliveira, Bruna S.
    Lima, Anna Luiza D.
    de Oliveira, Antonio Carlos P.
    Reis, Helton J.
    de Miranda, Aline S.
    Vieira, Erica M. L.
    Ribeiro, Fabiola M.
    Vieira, Luciene B.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington’s disease
    Rebeca P. M. Santos
    Roberta Ribeiro
    Talita H. Ferreira-Vieira
    Rosaria D. Aires
    Jessica M. de Souza
    Bruna S. Oliveira
    Anna Luiza D. Lima
    Antônio Carlos P. de Oliveira
    Helton J. Reis
    Aline S. de Miranda
    Erica M. L. Vieira
    Fabiola M. Ribeiro
    Luciene B. Vieira
    Scientific Reports, 12
  • [24] Unawareness of Deficits in Huntington's Disease
    Sitek, Emilia J.
    Thompson, Jennifer C.
    Craufurd, David
    Snowden, Julie S.
    JOURNAL OF HUNTINGTONS DISEASE, 2014, 3 (02) : 125 - 135
  • [25] Phosphoproteomic dysregulation in Huntington's disease mice is rescued by environmental enrichment
    Mees, Isaline
    Li, Shanshan
    Tran, Harvey
    Ang, Ching-Seng
    Williamson, Nicholas A.
    Hannan, Anthony J.
    Renoir, Thibault
    BRAIN COMMUNICATIONS, 2022, 4 (06)
  • [26] The effects of environmental enrichment as a treatment strategy for patients with Huntington's disease
    Thompson, J. A.
    Cruickshank, T.
    Penailillo, L.
    Davies, S.
    Georgiou-Karistianis, N.
    Barker, R.
    Ziman, M.
    MOVEMENT DISORDERS, 2012, 27 : S62 - S62
  • [27] Memory deficits in the transgenic rat model of Huntington's disease
    Zeef, Dagmar H.
    van Goethem, Nick P.
    Vlamings, Rinske
    Schaper, Frederic
    Jahanshahi, Ali
    Hescham, Sarah
    von Hoersten, Stephan
    Prickaerts, Jos
    Temel, Yasin
    BEHAVIOURAL BRAIN RESEARCH, 2012, 227 (01) : 194 - 198
  • [28] Commentary: the Flavonoid Baicalein rescues Synaptic Plasticity and memory Deficits in a mouse model of alzheimer's Disease
    Chirumbolo, Salvatore
    Bjorklund, Geir
    FRONTIERS IN NEUROLOGY, 2016, 7
  • [29] Selegiline rescues gait deficits and dopaminergic cells in subacute MPTP mouse model of Parkinson's disease
    Zhao, Q.
    Bai, Y.
    Fang, D.
    MOVEMENT DISORDERS, 2013, 28 : S300 - S300
  • [30] Selegiline rescues gait deficits and dopaminergic cells in a subacute MPTP mouse model of Parkinson's disease
    Zhao, Q.
    Bai, Y.
    Cai, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 331 - 331